Evaluation of the Efficacy and Safety of Lixisenatide Add-On Treatment to Basal Insulin Therapy Among T2DM Patients With Different Body Mass Indices From GetGoal Trials
Diabetology and Metabolic Syndrome - United Kingdom
doi 10.1186/s13098-015-0104-6
Full Text
Open PDFAbstract
Available in full text
Date
November 21, 2015
Authors
Publisher
Springer Science and Business Media LLC